Preliminary Assessment of [18F]BL40 in PET/CT Scans
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
CXCR4 is type of receptor that has been detected in more than twenty different subtypes of cancers. Most of these cancers are associated with negative symptoms that worsen over time resulting in great disability and poor function. There is a need for novel tracers to image CXCR4-expressing tumors for better detection, staging, and monitoring of aggressive cancers without the need for invasive biopsy procedures that may not always properly capture the extent of a patient's disease. This study looks to assess the safety and efficacy of a novel radiopharmaceutical known as 18F-BL40 through its use in a PET/CT scan. Participants will receive 2 PET/CT scans: 18F-BL40 and 18F-FDG as part of this study.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 19 lat i więcej.
- •Szacowany czas życia co najmniej 3 miesiące.
- •Ogólny stan zdrowia pozwalający na aktywność (ECOG 0-2).
- •Pacjenci z niedawno zdiagnozowanym lub nawracającym chłoniakiem dużych komórek B, szpiczakiem mnogim, chłoniakiem strefy brzeżnej, przewlekłą białaczką limfocytową lub makroglobulinemią Waldenströma.
✗ Disqualifies
- •Kobiety w ciąży lub karmiące piersią.
- •Osoby w złym stanie zdrowia (np. ostre choroby, niestabilne parametry życiowe).
- •Osoby, które nie mogą leżeć na plecach przez czas badania.
- •Osoby uczulone na składniki znacznika.
Simplified criteria — AI translation
Trial details
- Minimum age
- 19 Years
- Maximum age
- 100 Years
- Last updated (source)
- October 1, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
BC Cancer
Vancouver, Canada
Trial contact
Heather Saprunoff
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/2/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.